LENSAR, Inc. (LNSR)
NASDAQ: LNSR · IEX Real-Time Price · USD
4.655
-0.035 (-0.75%)
Jun 17, 2024, 2:38 PM EDT - Market open

LENSAR Revenue

LENSAR had revenue of $44.50M in the twelve months ending March 31, 2024, with 29.85% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.59M with 28.31% year-over-year growth. In the year 2023, LENSAR had annual revenue of $42.16M with 19.25% growth.

Revenue (ttm)
$44.50M
Revenue Growth
+29.85%
P/S Ratio
1.19
Revenue / Employee
$342,308
Employees
130
Market Cap
53.05M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202342.16M6.81M19.25%
Dec 31, 202235.36M899.00K2.61%
Dec 31, 202134.46M8.08M30.62%
Dec 31, 202026.38M-4.15M-13.58%
Dec 31, 201930.53M6.14M25.18%
Dec 31, 201824.39M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
DURECT 8.32M
Mobile-health Network Solutions 7.87M
BioXcel Therapeutics 1.76M
vTv Therapeutics 1.00M
Envoy Medical 297.00K
Revenue Rankings